Obsidian Therapeutics

About:

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Website: http://obsidiantx.com/

Twitter/X: obsidian_tx

Top Investors: Blue Owl, RA Capital Management, Alexandria Venture Investments, Wellington Management, Bristol-Myers Squibb

Description:

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer.The company's next-generation cell and gene therapies with pharmacologic operating systems provide exquisite control of protein activity in cells and create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs, enabling patients to improve on the current generation of cell therapies.